Emmaus (EMMA) CEO Lee Willis Buys 530,767 Shares

What Happened
Lee Willis, CEO and a director of Emmaus Life Sciences (EMMA), made a series of open‑market purchases (transaction code P) totaling 530,767 shares between May 30, 2025 and August 31, 2026. The reported purchases used weighted‑average prices and together cost roughly $18,126. These were purchases (insider buys), which market observers often view as more informative about insider sentiment than routine sales.

Key Details

• Transaction dates and reported weighted‑average prices:
  • 2025-05-30: 70,000 shares at $0.02 (weighted avg; range $0.01–$0.02) — $1,400
  • 2025-08-29: 170,000 shares at $0.01 (weighted avg; range $0.0109–$0.011) — $1,700
  • 2026-08-25: 46,000 shares at $0.04 (weighted avg; range $0.034–$0.039) — $1,840
  • 2026-08-27: 50,000 shares at $0.05 (weighted avg; range $0.044–$0.051) — $2,500
  • 2026-08-28: 94,767 shares at $0.06 (weighted avg; range $0.050–$0.075) — $5,686
  • 2026-08-31: 100,000 shares at $0.05 (weighted avg; range $0.046–$0.05) — $5,000
• Total acquired: 530,767 shares; total cash spent per filing: about $18,126.
• Footnotes: Each purchase price is a weighted average from multiple trades; specific per‑trade prices are given as ranges in the filing (see ranges above). The filer offered to provide detailed breakdowns upon request.
• Shares owned after the transactions: not specified in the data provided.
• Filing timeliness: Form 4 was filed on 2026-09-02 and reports trades through 2026-08-31 and earlier—this is later than the standard two‑business‑day Form 4 filing window, so the filing appears to be late.

Context

• These are open‑market purchases (not option exercises or gifts). Insider purchases can be interpreted as a positive signal, but they do not guarantee future performance.
• The dollar amounts are small (penny‑stock price levels), typical for microcap trading; liquidity and volatility can be high.
• Because the Form 4 appears to have been filed late, investors who track timely insider activity may have missed earlier disclosure; the filing does, however, document the purchases and provides price ranges for the trades.